Predictive value of integrated (18)F-FDG PET/MRI in the early response to nivolumab in patients with previously treated non-small cell lung cancer

BACKGROUND: The early response to treatment with immune-checkpoint inhibitors is difficult to evaluate. We determined whether changes in integrated [(18)F]-fluoro-2-deoxy-D-glucose positron emission tomography/MRI ((18)F-FDG PET/MRI) parameters after the first 2 weeks of antiprogrammed death-1 antib...

Descripción completa

Detalles Bibliográficos
Autores principales: Umeda, Yukihiro, Morikawa, Miwa, Anzai, Masaki, Ameshima, Shingo, Kadowaki, Maiko, Waseda, Yuko, Shigemi, Hiroko, Tsujikawa, Tetsuya, Kiyono, Yasushi, Okazawa, Hidehiko, Ishizuka, Tamotsu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Immunotherapy Biomarkers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7213911/
https://www.ncbi.nlm.nih.gov/pubmed/32345624
http://dx.doi.org/10.1136/jitc-2019-000349

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7213911/
https://www.ncbi.nlm.nih.gov/pubmed/32345624
http://dx.doi.org/10.1136/jitc-2019-000349

Ejemplares similares